Market Research Logo

Medical Marijuana Market Size By Application (Pain Management, Muscle Spasms, Nausea, Anorexia, Seizures, Others), By Route of Administration (Inhalation, Oral, Topical), By Distribution Channel (Dispensaries, Online), Industry Analysis Report, Regional O

Medical Marijuana Market Size By Application (Pain Management, Muscle Spasms, Nausea, Anorexia, Seizures, Others), By Route of Administration (Inhalation, Oral, Topical), By Distribution Channel (Dispensaries, Online), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, Italy, UK, Czech Republic, France, The Netherlands, Argentina, Chile, Peru, Colombia, Australia, Israel) Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 - 2024

Medical Marijuana Market will exceed USD 55.0 billion by 2024; as per a new research report.

Increase in number of geriatric people suffering from chronic pain caused due to neurology diseases, cancer, HIV/AIDS and arthritis will propel the medical marijuana market growth over the forecast period. According to the Boston University, School of Public Health, about 1 in 5 or 1,500 million people suffer from chronic pain, through the prevalence increasing with age globally.

Currently, 29 states in the U.S. along with Washington D.C. have approved the application of marijuana for medicinal purpose. The number of states in the U.S. receiving approval for medical marijuana use is expected to increase swiftly, hence drive the market growth. Furthermore, other emerging countries such as Israel and Australia have also contributed towards the growth of the market by approving the medicinal use of marijuana. Various ongoing research and development projects are also going in these countries to support the application of medical marijuana in the treatment of a range of conditions.

However, factors such as adverse side effects of marijuana, lack of safety data, strict regulatory norms set by local government bodies and difficulty in setting up marijuana business coverage will be major hindrances for global medical marijuana market.

Medical marijuana muscle spasms market segment is estimated to witness a CAGR of around 35% during the forecast period. The main cause of muscle spasm is multiple sclerosis; and around 90% patients with multiple sclerosis develop muscle spasms. Increasing prevalence of multiple sclerosis with an estimated 2.5 million people affected by the same will boost market growth.

The medical marijuana inhalation market segment was valued at USD 5,348.7 million in 2017 owing to controlled dosage rates and better absorption of medical marijuana into the body. In addition, the effects of inhaling marijuana can be perceived in few minutes of its administration with high peak concentrations, hence making it the preferred route of administration for medical marijuana.

Online medical marijuana market segment is forecasted to expand at a CAGR of 36.8% owing to factors such as availability of variety products, convenience, competitive costs and privacy. Furthermore, with online medical marijuana products, one can take advantage of an effective customer service and outstanding product knowledge, hence will boost the medical marijuana sales.

Israel medical marijuana market valued USD 39.5 million in 2017. Growing number of research and development studies pertaining to the application of medical marijuana will augment market growth in the region. In addition, recently a new reform was passed in Israel, where medical marijuana can be sold at ordinary pharmacies. This would enable the doctors in Israel to prescribe marijuana-based medications, thereby increasing the sales of medical marijuana.

Some of the prominent industry players in medical marijuana market are Canopy Growth, Aurora Cannabis, Inc., Medical Marijuana, Inc., GW Pharmaceuticals, Aphria, Inc., CanniMed Ltd., Tilray, Emerald Health Therapeutics, and MedReleaf Corp., among others. Increasing research and development activities undertaken collaboratively by these companies could bring few novel medical marijuana products to the market in the coming future. In addition, strategic mergers and acquisitions will also aid companies to expand the market in various geographies in order to sustain in the competitive market.


Chapter 1. Methodology
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical model and forecast
1.1.3. Industry insights and validation
1.1.4. Market definition and forecast parameters
1.2. Data sources
1.2.1. Secondary
1.2.2. Primary
Chapter 2. Executive Summary
2.1. Medical marijuana industry 360 degree synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Application trends
2.1.3. Route of administration trends
2.1.4. Distribution channel trends
2.1.5. Regional trends
Chapter 3. Medical Marijuana Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Increasing application of marijuana for a myriad of medical conditions and symptoms
3.3.1.2. Growing demand for medical marijuana legalization in several countries
3.3.1.3. Rising number of R&D and clinical trial activities
3.3.2. Industry pitfalls & challenges
3.3.2.1. Few side effects might hinder the market growth
3.3.2.2. Difficulty in medical marijuana business banking
3.4. Growth potential analysis
3.4.1. By application
3.4.2. By route of administration
3.4.3. By distribution channel
3.5. Porter's analysis
3.6. Competitive landscape, 2017
3.6.1. Business overview
3.6.2. Revenue analysis
3.6.3. Product landscape
3.6.4. Strategy dashboard
3.7. PESTEL analysis
3.8. Value chain analysis
3.9. Legal Requirement for Distribution of Medical Marijuana
3.10. Regulatory Landscape, by Country
3.10.1. US
3.10.2. Canada
3.10.3. The Netherlands
3.10.4. Israel
Chapter 4. Medical Marijuana Market, By Application
4.1. Global medical marijuana market share, by application, 2017 & 2024
4.2. Pain Management
4.2.1. Market estimates and forecast, by region, 2013 - 2024
4.2.2. Neuropathic Pain
4.2.2.1. Market estimates and forecast, by region, 2013 - 2024
4.2.3. Cancer Pain
4.2.3.1. Market estimates and forecast, by region, 2013 - 2024
4.2.4. Others
4.2.4.1. Market estimates and forecast, by region, 2013 - 2024
4.3. Muscle Spasms
4.3.1. Market estimates and forecast, by region, 2013 - 2024
4.4. Nausea
4.4.1. Market estimates and forecast, by region, 2013 - 2024
4.5. Anorexia
4.5.1. Market estimates and forecast, by region, 2013 - 2024
4.6. Seizures
4.6.1. Market estimates and forecast, by region, 2013 - 2024
4.7. Others
4.7.1. Market estimates and forecast, by region, 2013 - 2024
Chapter 5. Medical marijuana Market, By Route of Administration
5.1. Global medical marijuana market share, by route of administration, 2017 & 2024
5.2. Inhalation
5.2.1. Market estimates and forecast, by region, 2013 - 2024
5.3. Oral
5.3.1. Market estimates and forecast, by region, 2013 - 2024
5.4. Topical
5.4.1. Market estimates and forecast, by region, 2013 - 2024
Chapter 6. Medical marijuana Market, By Distribution Channel
6.1. Global medical marijuana market share, by distribution channel, 2017 & 2024
6.2. Dispensaries
6.2.1. Market estimates and forecast, by region, 2013 - 2024
6.3. Online
6.3.1. Market estimates and forecast, by region, 2013 - 2024
Chapter 7. Medical marijuana Market, By Region
7.1. Global medical marijuana market share, by region, 2017 & 2024
7.2. North America
7.2.1. Market estimates and forecast, by country, 2013 - 2024
7.2.2. Market estimates and forecast, by application, 2013 - 2024
7.2.2.1. Market estimates and forecast, by pain management, 2013 - 2024
7.2.3. Market estimates and forecast, by route of administration, 2013 - 2024
7.2.4. Market estimates and forecast, by distribution channel, 2013 - 2024
7.2.5. U.S.
7.2.5.1. Market estimates and forecast, by application, 2013 - 2024
7.2.5.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.2.5.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.2.5.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.2.6. Canada
7.2.6.1. Market estimates and forecast, by application, 2013 - 2024
7.2.6.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.2.6.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.2.6.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.3. Europe
7.3.1. Market estimates and forecast, by country, 2013 - 2024
7.3.2. Market estimates and forecast, by application, 2013 - 2024
7.3.2.1. Market estimates and forecast, by pain management, 2013 - 2024
7.3.3. Market estimates and forecast, by route of administration, 2013 - 2024
7.3.4. Market estimates and forecast, by distribution channel, 2013 - 2024
7.3.5. Germany
7.3.5.1. Market estimates and forecast, by application, 2013 - 2024
7.3.5.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.3.5.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.3.5.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.3.6. Italy
7.3.6.1. Market estimates and forecast, by application, 2013 - 2024
7.3.6.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.3.6.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.3.6.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.3.7. UK
7.3.7.1. Market estimates and forecast, by application, 2013 - 2024
7.3.7.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.3.7.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.3.7.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.3.8. Czech Republic
7.3.8.1. Market estimates and forecast, by application, 2013 - 2024
7.3.8.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.3.8.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.3.8.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.3.9. France
7.3.9.1. Market estimates and forecast, by application, 2013 - 2024
7.3.9.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.3.9.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.3.9.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.3.10. The Netherlands
7.3.10.1. Market estimates and forecast, by application, 2013 - 2024
7.3.10.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.3.10.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.3.10.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.3.11. Rest of Europe
7.3.11.1. Market estimates and forecast, by application, 2013 - 2024
7.3.11.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.3.11.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.3.11.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.4. Latin America
7.4.1. Market estimates and forecast, by country, 2013 - 2024
7.4.2. Market estimates and forecast, by application, 2013 - 2024
7.4.2.1. Market estimates and forecast, by pain management, 2013 - 2024
7.4.3. Market estimates and forecast, by route of administration, 2013 - 2024
7.4.4. Market estimates and forecast, by distribution channel, 2013 - 2024
7.4.5. Argentina
7.4.5.1. Market estimates and forecast, by application, 2013 - 2024
7.4.5.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.4.5.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.4.5.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.4.6. Chile
7.4.6.1. Market estimates and forecast, by application, 2013 - 2024
7.4.6.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.4.6.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.4.6.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.4.7. Peru
7.4.7.1. Market estimates and forecast, by application, 2013 - 2024
7.4.7.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.4.7.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.4.7.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.4.8. Colombia
7.4.8.1. Market estimates and forecast, by application, 2013 - 2024
7.4.8.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.4.8.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.4.8.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.5. Rest of the World
7.5.1. Market estimates and forecast, by country, 2013 - 2024
7.5.2. Market estimates and forecast, by application, 2013 - 2024
7.5.2.1. Market estimates and forecast, by pain management, 2013 - 2024
7.5.3. Market estimates and forecast, by route of administration, 2013 - 2024
7.5.4. Market estimates and forecast, by distribution channel, 2013 - 2024
7.5.5. Australia
7.5.5.1. Market estimates and forecast, by application, 2013 - 2024
7.5.5.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.5.5.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.5.5.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.5.6. Israel
7.5.6.1. Market estimates and forecast, by application, 2013 - 2024
7.5.6.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.5.6.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.5.6.3. Market estimates and forecast, by distribution channel, 2013 - 2024
Chapter 8. Company Profiles
8.1. Canopy Growth
8.1.1. Business overview
8.1.2. Financial data
8.1.3. Product landscape
8.1.4. Strategic outlook
8.1.5. SWOT analysis
8.2. Aphria, Inc.
8.2.1. Business overview
8.2.2. Financial data
8.2.3. Product landscape
8.2.4. Strategic outlook
8.2.5. SWOT analysis
8.3. Aurora Cannabis, Inc.
8.3.1. Business overview
8.3.2. Financial data
8.3.3. Product landscape
8.3.4. Strategic outlook
8.3.5. SWOT analysis
8.4. GW Pharmaceuticals
8.4.1. Business overview
8.4.2. Financial data
8.4.3. Product landscape
8.4.4. Strategic outlook
8.4.5. SWOT analysis
8.5. mCig
8.5.1. Business overview
8.5.2. Financial data
8.5.3. Product landscape
8.5.4. Strategic outlook
8.5.5. SWOT analysis
8.6. Medical Marijuana, Inc.
8.6.1. Business overview
8.6.2. Financial data
8.6.3. Product landscape
8.6.4. Strategic outlook
8.6.5. SWOT analysis
8.7. United Cannabis
8.7.1. Business overview
8.7.2. Financial data
8.7.3. Product landscape
8.7.4. Strategic outlook
8.7.5. SWOT analysis
8.8. MedReleaf
8.8.1. Business overview
8.8.2. Financial data
8.8.3. Product landscape
8.8.4. Strategic outlook
8.8.5. SWOT analysis
8.9. The Supreme Cannabis Company
8.9.1. Business overview
8.9.2. Financial data
8.9.3. Product landscape
8.9.4. Strategic outlook
8.9.5. SWOT analysis
8.10. CanniMed Ltd.
8.10.1. Business overview
8.10.2. Financial data
8.10.3. Product landscape
8.10.4. Strategic outlook
8.10.5. SWOT analysis
8.11. Medical Marijuana, Inc.
8.11.1. Business overview
8.11.2. Financial data
8.11.3. Product landscape
8.11.4. Strategic outlook
8.11.5. SWOT analysis
8.12. Tilray
8.12.1. Business overview
8.12.2. Financial data
8.12.3. Product landscape
8.12.4. Strategic outlook
8.12.5. SWOT analysis
8.13. Emerald Health Therapeutics
8.13.1. Business overview
8.13.2. Financial data
8.13.3. Product landscape
8.13.4. Strategic outlook
8.13.5. SWOT analysis
8.14. Lexaria Corporation
8.14.1. Business overview
8.14.2. Financial data
8.14.3. Product landscape
8.14.4. Strategic outlook
8.14.5. SWOT analysis
8.15. Cannabis Sativa, Inc.
8.15.1. Business overview
8.15.2. Financial data
8.15.3. Product landscape
8.15.4. Strategic outlook
8.15.5. SWOT analysis
8.16. Insys Therapeutics, Inc.
8.16.1. Business overview
8.16.2. Financial data
8.16.3. Product landscape
8.16.4. Strategic outlook
8.16.5. SWOT analysis
8.17. Corbus Pharmaceuticals
8.17.1. Business overview
8.17.2. Financial data
8.17.3. Product landscape
8.17.4. Strategic outlook
8.17.5. SWOT analysis
8.18. GBSciences, Inc.
8.18.1. Business overview
8.18.2. Financial data
8.18.3. Product landscape
8.18.4. Strategic outlook
8.18.5. SWOT analysis
8.19. The Cronos Group
8.19.1. Business overview
8.19.2. Financial data
8.19.3. Product landscape
8.19.4. Strategic outlook
8.19.5. SWOT analysis
8.20. The Hydropothecary Corporation
8.20.1. Business overview
8.20.2. Financial data
8.20.3. Product landscape
8.20.4. Strategic outlook
8.20.5. SWOT analysis
8.21. Namaste Technologies Inc
8.21.1. Business overview
8.21.2. Financial data
8.21.3. Product landscape
8.21.4. Strategic outlook
8.21.5. SWOT analysis
Data Tables
TABLE 1. Medical marijuana industry 360 degree synopsis, 2013 - 2024
TABLE 2. Medical marijuana market, 2013 - 2024, (USD Million)
TABLE 3. Global medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 4. Global medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 5. Global medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 6. Global medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 7. Global medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 8. Global medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 9. Global medical marijuana market by region, 2013 - 2017 (USD Million)
TABLE 10. Global medical marijuana market by region, 2018 - 2024 (USD Million)
TABLE 11. Industry impact forces
TABLE 12. Pain management market by region, 2013 - 2017 (USD Million)
TABLE 13. Pain management market by region, 2018 - 2024 (USD Million)
TABLE 14. Neuropathic pain market by region, 2013 - 2017 (USD Million)
TABLE 15. Neuropathic pain market by region, 2018 - 2024 (USD Million)
TABLE 16. Cancer pain market by region, 2013 - 2017 (USD Million)
TABLE 17. Cancer pain market by region, 2018 - 2024 (USD Million)
TABLE 18. Others market by region, 2013 - 2017 (USD Million)
TABLE 19. Others market by region, 2018 - 2024 (USD Million)
TABLE 20. Muscle spasms market by region, 2013 - 2017 (USD Million)
TABLE 21. Muscle spasms market by region, 2018 - 2024 (USD Million)
TABLE 22. Nausea market by region, 2013 - 2017 (USD Million)
TABLE 23. Nausea market by region, 2013 - 2017 (USD Million)
TABLE 24. Anorexia market by region, 2013 - 2017 (USD Million)
TABLE 25. Anorexia market by region, 2018 - 2024 (USD Million)
TABLE 26. Seizures market by region, 2013 - 2017 (USD Million)
TABLE 27. Seizures market by region, 2018 - 2024 (USD Million)
TABLE 28. Others market by region, 2013 - 2017 (USD Million)
TABLE 29. Others market by region, 2018 - 2024 (USD Million)
TABLE 30. Inhalation market by region, 2013 - 2017 (USD Million)
TABLE 31. Inhalation market by region, 2018 - 2024 (USD Million)
TABLE 32. Oral market by region, 2013 - 2017 (USD Million)
TABLE 33. Oral market by region, 2018 - 2024 (USD Million)
TABLE 34. Topical market by region, 2013 - 2017 (USD Million)
TABLE 35. Topical market by region, 2018 - 2024 (USD Million)
TABLE 36. Dispensaries market by region, 2013 - 2017 (USD Million)
TABLE 37. Dispensaries market by region, 2018 - 2024 (USD Million)
TABLE 38. Online market by region, 2013 - 2017 (USD Million)
TABLE 39. Online market by region, 2018 - 2024 (USD Million)
TABLE 40. North America medical marijuana market, by country, 2013 - 2017, (USD Million)
TABLE 41. North America medical marijuana market, by country, 2018 - 2024 (USD Million)
TABLE 42. North America medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 43. North America medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 44. North America medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 45. North America medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 46. North America medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 47. North America medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 48. U.S. medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 49. U.S. medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 50. U.S. medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 51. U.S. medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 52. U.S. medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 53. U.S. medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 54. Canada medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 55. Canada medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 56. Canada medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 57. Canada medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 58. Canada medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 59. Canada medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 60. Europe medical marijuana market, by country, 2013 - 2017, (USD Million)
TABLE 61. Europe medical marijuana market, by country, 2018 - 2024 (USD Million)
TABLE 62. Europe medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 63. Europe medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 64. Europe medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 65. Europe medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 66. Europe medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 67. Europe medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 68. Germany medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 69. Germany medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 70. Germany medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 71. Germany medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 72. Germany medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 73. Germany medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 74. Italy medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 75. Italy medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 76. Italy medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 77. Italy medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 78. Italy medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 79. Italy medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 80. UK medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 81. UK medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 82. UK medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 83. UK medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 84. UK medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 85. UK medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 86. Czech Republic medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 87. Czech Republic medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 88. Czech Republic medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 89. Czech Republic medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 90. Czech Republic medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 91. Czech Republic medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 92. France medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 93. France medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 94. France medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 95. France medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 96. France medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 97. France medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 98. The Netherlands medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 99. The Netherlands medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 100. The Netherlands medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 101. The Netherlands medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 102. The Netherlands medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 103. The Netherlands medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 104. Rest of Europe medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 105. Rest of Europe medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 106. Rest of Europe medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 107. Rest of Europe medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 108. Rest of Europe medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 109. Rest of Europe medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 110. Latin America medical marijuana market, by country, 2013 - 2017, (USD Million)
TABLE 111. Latin America medical marijuana market, by country, 2018 - 2024 (USD Million)
TABLE 112. Latin America medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 113. Latin America medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 114. Latin America medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 115. Latin America medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 116. Latin America medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 117. Latin America medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 118. Argentina medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 119. Argentina medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 120. Argentina medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 121. Argentina medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 122. Argentina medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 123. Argentina medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 124. Chile medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 125. Chile medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 126. Chile medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 127. Chile medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 128. Chile medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 129. Chile medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 130. Peru medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 131. Peru medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 132. Peru medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 133. Peru medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 134. Peru medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 135. Peru medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 136. Colombia medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 137. Colombia medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 138. Colombia medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 139. Colombia medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 140. Colombia medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 141. Colombia medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 142. RoW medical marijuana market, by country, 2013 - 2017, (USD Million)
TABLE 143. RoW medical marijuana market, by country, 2018 - 2024 (USD Million)
TABLE 144. RoW medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 145. RoW medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 146. RoW medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 147. RoW medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 148. RoW medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 149. RoW medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 150. Australia medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 151. Australia medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 152. Australia medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 153. Australia medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 154. Australia medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 155. Australia medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 156. Israel medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 157. Israel medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 158. Israel medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 159. Israel medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 160. Israel medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 161. Israel medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
Charts & Figures
FIG. 1 Industry segmentation
FIG. 2 Global medical marijuana market, 2013 - 2024 (USD billion)
FIG. 3 Growth potential analysis, by application
FIG. 4 Growth potential analysis, by route of administration
FIG. 5 Growth potential analysis, by distribution channel
FIG. 6 Porter's analysis
FIG. 7 Strategy dashboard
FIG. 8 PESTEL analysis
FIG. 9 Value chain analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report